{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T21:02:27Z","timestamp":1698699747100},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:00:00Z","timestamp":1168992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Soc Psychiat Epidemiol"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s00127-006-0149-9","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T07:53:28Z","timestamp":1169020408000},"page":"181-188","source":"Crossref","is-referenced-by-count":16,"title":["Antidepressant utilization in primary care in a Spanish region"],"prefix":"10.1007","volume":"42","author":[{"given":"Amalia","family":"Ubeda","sequence":"first","affiliation":[]},{"given":"Encarna","family":"Cardo","sequence":"additional","affiliation":[]},{"given":"Noelia","family":"Sell\u00e9s","sequence":"additional","affiliation":[]},{"given":"Rocio","family":"Broseta","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Luis","family":"Trillo","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Fern\u00e1ndez-Llim\u00f3s","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,1,17]]},"reference":[{"issue":"Suppl 420","key":"149_CR1","first-page":"21","volume":"109","author":"J Alonso","year":"2004","unstructured":"Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, Girolamo G, Graaf R, Demyttenaere K, Gasquet I, et al. (2004) Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 109(Suppl 420):21\u201327","journal-title":"Acta Psychiatr Scand"},{"key":"149_CR2","first-page":"9","volume":"90","author":"C Balm\u00f3n Cruz","year":"2004","unstructured":"Balm\u00f3n Cruz C, Dorado-Primo JA (2004) Detecci\u00f3n y prevalencia de trastornos depresivos geri\u00e1tricos en atenci\u00f3n primaria. Rev AEN 90:9\u201320","journal-title":"Rev AEN"},{"key":"149_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0212-6567(02)70578-7","volume":"29","author":"E Gabarr\u00f3n-Hortal","year":"2002","unstructured":"Gabarr\u00f3n-Hortal E, Vida-Royo JM, Haro-Abad JM, Boix-Soriano I, Jover-Blanca A, Arenas-Prat M (2002) Prevalence and detection of depressive disorders in primary care. Aten Primaria 29:329\u2013336","journal-title":"Aten Primaria"},{"issue":"Suppl 420","key":"149_CR4","first-page":"55","volume":"109","author":"J Alonso","year":"2004","unstructured":"Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, Girolamo G, Graaf R, Demyttenaere K, Gasquet I, et al. (2004) Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 109(Suppl 420):55\u201364","journal-title":"Acta Psychiatr Scand"},{"key":"149_CR5","first-page":"161","volume":"108","author":"MP Alonso","year":"1997","unstructured":"Alonso MP, Abajo FJ, Mart\u00ednez JJ, Montero D, Mart\u00edn-Serrano G, Madurga M (1997) Evoluci\u00f3n del consumo de antidepresivos en Espa\u00f1a. Impacto de los inhibidores selectivos de la recaptaci\u00f3n de serotonina. Med Clin (Barc) 108:161\u2013166","journal-title":"Med Clin (Barc)"},{"key":"149_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/002076402128783109","volume":"48","author":"S Ruiz-Doblado","year":"2002","unstructured":"Ruiz-Doblado S, Caraballo-Camacho ML (2002) Pharmacoepidemiological patterns of antidepressant prescribing in primary care in rural Spain (1995\u20131999). Int J Soc Psychiatry 48:71\u201377","journal-title":"Int J Soc Psychiatry"},{"key":"149_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/pds.891","volume":"13","author":"C las Cuevas De","year":"2004","unstructured":"De las Cuevas C, Sanz E (2004) Do therapeutic indications of antidepressants change from one year to another? Pharmacoepidemiol Drug Safe 13:309\u2013314","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"149_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0306312704042620","volume":"34","author":"D Healy","year":"2004","unstructured":"Healy D (2004) Shaping the intimate: influence on the experience of everyday nerves. Soc Stud Sci 34:219\u2013245","journal-title":"Soc Stud Sci"},{"key":"149_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.331.7509.155","volume":"331","author":"J Moncrief","year":"2005","unstructured":"Moncrief J, Kirsch I (2005) Efficacy of antidepressants in adults. BMJ 331:155\u2013157","journal-title":"BMJ"},{"issue":"Suppl 420","key":"149_CR10","first-page":"47","volume":"109","author":"J Alonso","year":"2004","unstructured":"Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, Girolamo G, Graaf R, Demyttenaere K, Gasquet I, et al. (2004) Use of mental health service in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scan 109(Suppl 420):47\u201354","journal-title":"Acta Psychiatr Scan"},{"issue":"Suppl 1","key":"149_CR11","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1046\/j.1524-4733.6.s1.6.x","volume":"6","author":"F Anto\u00f1anzas","year":"2003","unstructured":"Anto\u00f1anzas F (2003) Challenges to achieving value in drug spending in a decentralized country: the Spanish case. Value Health 6(Suppl 1):S52\u2013S63","journal-title":"Value Health"},{"key":"149_CR12","unstructured":"Aula de Opini\u00f3n Sanitaria: Gesti\u00f3n de la prestaci\u00f3n farmac\u00e9utica. 3\u00aa Reuni\u00f3n Sept. 2004. http:\/\/www.elglobal.net\/DocumentacionPdf\/PrestacFarm.pdf . Modified September 2004. Cited 15 June 2006"},{"key":"149_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-8510(03)00113-1","volume":"67","author":"J Puig-Junoy","year":"2004","unstructured":"Puig-Junoy J (2004) Incentives and pharmaceutical reimbursement reforms in Spain. Health Policy 67:149\u2013165","journal-title":"Health Policy"},{"key":"149_CR14","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (Norway) (2000) ATC index with DDDs"},{"key":"149_CR15","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.5694\/j.1326-5377.2004.tb06350.x","volume":"181","author":"A Mant","year":"2004","unstructured":"Mant A, Rendle VA, Hall WD, Mitchell PB, Montgomery WS, McManus PR, Hichie IB (2004) Making new choices about antidepressants in Australia: the long view 1975\u20132002. Med J Aust 181:S21-S24","journal-title":"Med J Aust"},{"key":"149_CR16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5694\/j.1326-5377.2000.tb139294.x","volume":"173","author":"P McManus","year":"2000","unstructured":"McManus P, Mant A, Mitchell PB, Montgomery WS, Marley J, Auland ME (2000) Recent trends in the use of antidepressants drugs in Australia, 1990\u20131998. Med J Aust 173:458\u2013461","journal-title":"Med J Aust"},{"key":"149_CR17","first-page":"72","volume":"6","author":"P Codo\u00f1er-L\u00f3pez","year":"2004","unstructured":"Codo\u00f1er-L\u00f3pez P, Barber\u00e1-Gonz\u00e1lez T, Sanahuja-Santaf\u00e9 MA, Moreno-Royo L (2004) Antipsic\u00f3ticos at\u00edpicos versus t\u00edpicos: estudio descriptivo del consumo en la Comunidad Valenciana en el per\u00edodo 2000\u20132003. Pharm Care Esp 6:72\u201378","journal-title":"Pharm Care Esp"},{"key":"149_CR18","first-page":"121","volume":"28","author":"Ministerio Sanidady Consumo","year":"2004","unstructured":"Ministerio Sanidady Consumo (2004) Grupos terap\u00e9uticos y principios activos de mayor consumo en el sistema nacional de salud durante 2003. Inf Ter Sist Nal Salud 28:121\u2013124","journal-title":"Inf Ter Sist Nal Salud"},{"key":"149_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1157\/13079144","volume":"36","author":"C Vedia-Urgell","year":"2005","unstructured":"Vedia-Urgell C, Bonet-Monne S, Forcada-Vega C, Parellada-Esquius N (2005) Study of the use of psychiatric drugs in primary care. Aten Primaria 36:239\u2013247","journal-title":"Aten Primaria"},{"key":"149_CR20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00127-005-0968-0","volume":"40","author":"CA Beck","year":"2005","unstructured":"Beck CA, Patten SB, Williams JVA, Wang JL, Currie SR, Maxwell CJ, El-Guebaly N (2005) Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol 40:799\u2013807","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"149_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00228-004-0726-3","volume":"60","author":"WE Meijer","year":"2004","unstructured":"Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA (2004) Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 60:57\u201361","journal-title":"Eur J Clin Pharmacol"},{"key":"149_CR22","first-page":"90","volume":"9","author":"JM Baena D\u00edez","year":"1999","unstructured":"Baena D\u00edez JM, Lopez-Mompo C, Fuentes Camps EM, Bragulat Martin A, Cucurull Folguera E, Hidalgo Garcia A, Tomas Peregrina J (1999) Evoluci\u00f3n del tratamiento famacol\u00f3gico de las depresiones (1989\u20131996): la irresistible ascensi\u00f3n de los inhibidores de la recaptaci\u00f3n de serotonina. MEDIFAM 9:90\u201397","journal-title":"MEDIFAM"},{"key":"149_CR23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00228-003-0692-1","volume":"59","author":"E Poluzzi","year":"2004","unstructured":"Poluzzi E, Motola D, Silvani C, De Ponti F, Vaccheri A, Montanaro N (2004) Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. Eur J Clin Pharmacol 59:825\u201331","journal-title":"Eur J Clin Pharmacol"},{"key":"149_CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(99)00147-0","volume":"59","author":"RA Lawrenson","year":"2000","unstructured":"Lawrenson RA, Tyrer F, Newson RB, Farmer RDT (2000) Treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affective Dis 59:149\u2013157","journal-title":"J Affective Dis"},{"key":"149_CR25","unstructured":"Depression: management of depression in primary and secondary care. NICE Clinical guideline 23. http:\/\/www.nice.org.uk\/CG023NICEguideline . Modified December 2004. Cited 28 Jan 2006"},{"key":"149_CR26","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4088\/JCP.v65n1208","volume":"65","author":"EM Whyte","year":"2004","unstructured":"Whyte EM, Basinski J, Farhi P, Dew MA, Begley A, Mulsant BH, Reynolds CF (2004) Geriatric depression treatment in non responders to selective serotonin reuptake inhibitors. J Clin Psychiatry 65:1634\u201341","journal-title":"J Clin Psychiatry"},{"key":"149_CR27","first-page":"257","volume":"3","author":"Real","year":"2004","unstructured":"Real M (2004) Gen\u00e9ricos: \u00bfLa asignatura pendiente de los m\u00e9dicos? Rev Esp Econ Salud 3: 257\u2013259. http:\/\/www.economiadelasalud.com\/Ediciones\/13\/08_en portada\/genericos.htm","journal-title":"Rev Esp Econ Salud"},{"key":"149_CR28","doi-asserted-by":"crossref","unstructured":"Garc\u00eda AJ, Martos F, Mart\u00edn A, S\u00e1nchez F (2004) A prop\u00f3sito de un caso. \u00bfSirven los gen\u00e9ricos para moderar\u00a0el gasto en hipertensi\u00f3n? Gac Sanit [on line] 18:137\u2013144 [cited 2006 June 15]. Available from: http:\/\/www.scielo.isciii.es\/scielo.php?script=sci_ arttext&pid=S0213\u201391112004000200009&lng=pt&nrm=iso","DOI":"10.1157\/13059285"},{"key":"149_CR29","unstructured":"Costa-Font J, Puig-Junoy J (2004) Regulatory ambivalence and the limitations of pharmaceutical policy in Spain. Economics Working Papers 762. Department of Economics and Business, Universitat Pompeu Fabra. Available from: http:\/\/www.econ.upf.edu\/docs\/papers\/downloads\/762.pdf . Cited 15 June 2006"},{"key":"149_CR30","unstructured":"Ministerio de Sanidad y Consumo. El mercado de gen\u00e9ricos en Espa\u00f1a contin\u00faa al alza y alcanza ya el 7,68% en 2005, un punto m\u00e1s que el a\u00f1o anterior. Noticia N\u00b0 171992. http:\/\/www.noticias.info\/asp\/aspcomunicados.asp?nid=171992 . Modified 28 April 2006. Cited 28 June 2006"},{"key":"149_CR31","unstructured":"Informe del grupo de trabajo sobre gasto sanitario-IGAE. Indicadores relacionados con el gasto. Gasto en Farmacia. 297\u2013325 http:\/\/www.documentacion.meh.es\/doc\/PortalVarios\/FinanciacionTerritorial\/Autonomica\/IGTGS2005.pdf . Modified July 2005. Cited 28 June 2006"},{"key":"149_CR32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0168-8510(00)00100-7","volume":"54","author":"G L\u00f3pez-Casasnovas","year":"2000","unstructured":"L\u00f3pez-Casasnovas G, Puig-Junoy J (2000) Review of the literature on reference pricing. Health Policy 54:87\u2013123","journal-title":"Health Policy"},{"key":"149_CR33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00019053-200220090-00002","volume":"20","author":"LL Ioannides-Demos","year":"2002","unstructured":"Ioannides-Demos LL, Ibrahim JE, McNeil JJ (2002) Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilization and health outcomes. Pharmacoeconomics 20:577\u2013591","journal-title":"Pharmacoeconomics"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-006-0149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00127-006-0149-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-006-0149-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T19:33:48Z","timestamp":1587324828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00127-006-0149-9"}},"subtitle":["Impact of generic and reference-based pricing policy (2000\u20132004)"],"short-title":[],"issued":{"date-parts":[[2007,1,17]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1007\/s00127-006-0149-9","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,17]]}}}